Is it safe to take Effexor (venlafaxine) and Cymbalta (duloxetine) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Combining Effexor (Venlafaxine) and Cymbalta (Duloxetine) Is Not Safe

It is unsafe to take Effexor (venlafaxine) and Cymbalta (duloxetine) together due to the high risk of serotonin syndrome, which can be life-threatening. 1, 2 Both medications are serotonin and norepinephrine reuptake inhibitors (SNRIs) that work through similar mechanisms, creating a dangerous redundancy when combined.

Why This Combination Is Dangerous

Pharmacological Overlap

  • Both medications inhibit the reuptake of serotonin and norepinephrine, but with different potencies:
    • Venlafaxine has a 30:1 ratio favoring serotonin reuptake inhibition 2
    • Duloxetine has a more balanced 10:1 ratio for serotonin:norepinephrine 2
  • Taking both simultaneously creates excessive levels of these neurotransmitters

Documented Risks

  • Fatal overdose has been reported with this specific combination, with postmortem blood concentrations of 24 mg/L (venlafaxine) and 0.97 mg/L (duloxetine) 3
  • Serotonin syndrome can develop rapidly (within hours) and progress to death 3
  • Even in non-fatal cases, the combination has led to serious toxicity requiring emergency intervention 4

Signs of Serotonin Syndrome

If someone has taken both medications, watch for:

  • Mental status changes: confusion, agitation
  • Autonomic instability: hyperthermia, tachycardia, hypertension
  • Neuromuscular abnormalities: tremor, rigidity, myoclonus
  • Other symptoms: diaphoresis, diarrhea, headache

Alternative Approaches

If Currently Taking One SNRI

  • Do not add the second SNRI
  • If switching between these medications is necessary:
    1. Gradually taper the first medication (over 2-4 weeks)
    2. Allow a washout period
    3. Start the new medication at a low dose 5

For Treatment-Resistant Depression

  • Consider alternative augmentation strategies:
    • Adding an antidepressant from a different class
    • Augmentation with mood stabilizers or atypical antipsychotics
    • Non-pharmacological approaches (TMS, ECT)

Important Considerations

  • Both medications can interact with other serotonergic drugs, including:
    • MAO inhibitors (absolutely contraindicated) 1, 5
    • Opioids 1
    • Triptans
    • Other antidepressants

Clinical Pearls

  • While there are rare case reports of successful combination therapy with an SSRI added to venlafaxine 6, these are exceptions rather than the rule and were conducted under close medical supervision
  • The risk of serotonin syndrome increases dramatically when two SNRIs are combined, as they affect the same neurotransmitter systems
  • Both medications also have overlapping side effect profiles, potentially worsening adverse effects like nausea, dry mouth, dizziness, and hypertension 2

If you are currently taking both medications, contact your healthcare provider immediately for guidance on safely discontinuing one of them.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Serotonin and Norepinephrine Reuptake Inhibitors.

Handbook of experimental pharmacology, 2019

Research

Fatal overdose with a combination of SNRIs venlafaxine and duloxetine.

Forensic science, medicine, and pathology, 2019

Research

Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009

Guideline

Switching from Duloxetine to Fluoxetine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.